Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01660191 · ClinicalTrials.gov registry record · Phase 4
A Study Comparing CoQ10 Levels While Taking 3 Different Statins
A Phase 4 study of Hypercholesterolemia, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 134
- Enrollment target
- 1
- Study location
NCT01660191: Completed Phase 4 study of Hypercholesterolemia, sponsored by University of Kansas Medical Center.
NCT01660191 is a Phase 4 study of Hypercholesterolemia that has completed, run by University of Kansas Medical Center. The registered enrollment target is 134 participants, below the 815-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01660191, a Phase 4 study of Hypercholesterolemia, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 134 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if Pitavastatin lowers CoQ10 less than Atorvastatin or Rosuvastatin.
Primary Outcome
Change in levels will be measured by taking difference between Baseline and Week 12 measures.
Conditions Studied
Interventions
- DRUG Atorvastatin 20mg
- DRUG Pitavastin 4mg
- DRUG Rosuvastatin 5mg
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-10 |
| Phase | Phase 4 |
What the finished NCT01660191 record still lists
NCT01660191 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 815-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Hypercholesterolemia appearing as the primary indexed condition, and to 3 interventions - of which Atorvastatin 20mg is the first listed.
NCT01660191 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT01660191 about?
NCT01660191 is a clinical study titled "A Study Comparing CoQ10 Levels While Taking 3 Different Statins". The purpose of this study is to determine if Pitavastatin lowers CoQ10 less than Atorvastatin or Rosuvastatin.
What is the current status of trial NCT01660191?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 134 participants. The study started on 2011-12. Estimated completion is 2013-10.
What conditions does trial NCT01660191 study?
This clinical trial studies the following conditions: Hypercholesterolemia.
What interventions are being tested in trial NCT01660191?
The interventions under investigation include: Atorvastatin 20mg (DRUG), Pitavastin 4mg (DRUG), Rosuvastatin 5mg (DRUG).
Who is sponsoring clinical trial NCT01660191?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01660191 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01660191's enrollment target sits among peer trials
134 33rd of 62 higher than 30 of 62 other Hypercholesterolemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypercholesterolemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
COMPLETED · Phase 4
-
Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol
COMPLETED · Phase 4
-
Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol
COMPLETED · Phase 4
-
Cholesterol and Pharmacogenetic Study
COMPLETED · Phase 4
-
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
COMPLETED · Phase 4
-
Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia